NCT05065957 2025-04-30
Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer
InnoPharmax Inc.
Phase 2/3 Recruiting
Clinical Trials
10 trialsNCT03252808 2024-12-09
Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients with Unresectable Pancreatic Cancer.
Takara Bio Inc.
Phase 1 Active not recruiting
NCT01285557 2024-09-19
DIGEST
Taiho Oncology, Inc.
Phase 3 Terminated
NCT03382600 2024-06-11
KEYNOTE-659
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT00284258 2012-11-02
Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer
Taiho Pharmaceutical Co., Ltd.
Phase 2/3 Completed
NCT00498225 2012-11-02
GEST
Taiho Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT00150670 2011-07-07
Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer
Taiho Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT00152217 2011-07-07
Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)
Taiho Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT00960349 2011-06-14
Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients
AstraZeneca
Phase 1 Completed
NCT00195572 2009-08-13
Study Evaluating Isovorin in Advanced/Recurrent Gastric Cancer
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 3 Completed